Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Regeneron Pharmaceuticals said on Monday a combination of its experimental drug and Novo Nordisk's obesity drug Wegovy helped ...

Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering ...

Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

New licensing agreement with Hansoh Pharma provides Regeneron with HS-20094, a GLP-1/GIP receptor agonist in advanced stages of clinical development in China. Phase 2 data suggest ...

Halofuginone shows promise for weight loss by boosting key metabolic regulators. Overweight and obesity have quickly become ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

For Poolbeg Pharma, the question is not simply whether it can fund its ambitions, but whether its pipeline can justify them.

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...

Under RFK Jr., HHS has begun updating the nutritional guidelines, but with MAHA involved, concerns about misinformation and ...

CHENNAI: The US Food and Drug Administration (FDA) on Saturday officially approved Moderna’s next-generation COVID-19 vaccine ...